Emerging GM3 Regulated Biomarkers in Malignant Melanoma

Gangliosides, GSLs, are expressed in the outer leaflet of the plasma membrane of animal cells and involved in a variety of functions, including serving as antigens, receptors for bacterial toxins, mediators of cell adhesion, and mediators and modulators of signal transduction. Moreover, the accumulated lines of evidence have shown that gangliosides play pivotal roles in cancer metastasis. As the first and simplest member in the metabolic series of the ganglioside family, GM3 is a metabolic precursor of more complex natural gangliosides, which in turn determines their contents and biological functions in cells and tissues. GM3 has been demon‐ strated to be involved in regulation of various processes including cell proliferation, differen‐ tiation, apoptosis, embryogenesis and oncogenesis, etc. However, it is difficult to understand the defined functional concepts of GM3 in cancer metastasis because GM3 indirectly exert their effects via regulating target genes.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5772/54941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Gelsolin affects the migratory ability of human colon adenocarcinoma and melanoma cells.

  2012cited by this paper
• GM3 suppresses anchorage‐independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells

  2011cited by this paper
• New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic Advances

  2011cited by this paper
• E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression

  2011cited by this paper
• Changing the Nature of Melanoma Cells by Manipulation of Ganglioside Expression

  2011cited by this paper
• GM3 Upregulation of matrix metalloproteinase-9 possibly through PI3K, AKT, RICTOR, RHOGDI-2, and TNF-A pathways in mouse melanoma B16 cells.

  2011cited by this paper
• KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9

  2010cited by this paper
• Caveolin‐1 tumor‐promoting role in human melanoma

  2009influential reference
• De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.

  2009influential reference
• High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients

  2009cited by this paper
• Applications of genomics in melanoma oncogene discovery.

  2009cited by this paper
• Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway.

  2009cited by this paper
• TNF: a moonlighting protein at the interface between cancer and infection.

  2008cited by this paper
• Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis

  2008cited by this paper
• Berberine Suppresses TNF-α-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells

  2008cited by this paper
• GM3 Signals Regulating TNF-Alpha Expression Are Mediated by Rictor and Arhgdib in Mouse Melanoma B16 Cells

  2008cited by this paper
• Cytokine sensitivity of metastatic human melanoma cell lines -simultaneous inhibition of proliferation and enhancement of gelatinase activity

  2008cited by this paper
• The Src signaling pathway: a potential target in melanoma and other malignancies

  2007cited by this paper
• Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53

  2007cited by this paper
• Tumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited

  2007cited by this paper
• The role of adhesion molecules, &agr;v&bgr;3, &agr;v&bgr;5 and their ligands in the tumor cell and endothelial cell adhesion

  2007cited by this paper
• Different caveolin isoforms in the retina of melanoma malignum affected human eye

  2007cited by this paper
• Ganglioside GD1a Negatively Regulates Matrix Metalloproteinase-9 Expression in Mouse FBJ Cell Lines at the Transcriptional Level

  2007cited by this paper
• Positive regulation of tumor necrosis factor-alpha by ganglioside GM3 through Akt in mouse melanoma B16 cells.

  2007cited by this paper
• Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.

  2006influential reference
• Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase–Akt–necrosis factor kappa B signaling cascade in human melanoma cells

  2006cited by this paper
• Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility

  2006cited by this paper
• Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling.

  2006cited by this paper
• Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells:Augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content

  2006cited by this paper
• STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases.

  2006cited by this paper
• Growth and Metastasis of Murine Mammary Carcinomas 5 Integrins in β 3 and β A Direct Test of Potential Roles for Updated

  2005cited by this paper
• The E. Donnall Thomas Lecture

  2005cited by this paper
• A Direct Test of Potential Roles for β3 and β5 Integrins in Growth and Metastasis of Murine Mammary Carcinomas

  2005cited by this paper
• Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression

  2005cited by this paper
• Reduced metastasis of transgenic mammary cancer in urokinase‐deficient mice

  2005cited by this paper
• Role of apaf-1 in melanoma drug resistance and apoptosis.

  2005cited by this paper
• Expression of STAT proteins and interferon receptors in benign and malignant melanocytic lesions: Correlation with recurrence.

  2004cited by this paper
• Molecular determinants of human uveal melanoma invasion and metastasis

  2004cited by this paper
• Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.

  2004cited by this paper
• Antisense oligodeoxynucleotides for urokinase‐plasminogen activator receptor have anti‐invasive and anti‐proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice

  2004cited by this paper
• Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins

  2004cited by this paper
• Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis

  2004cited by this paper
• Effector Cell-Derived Lymphotoxin α and Fas Ligand, but not Perforin, Promote Tc1 and Tc2 Effector Cell-Mediated Tumor Therapy in Established Pulmonary Metastases

  2004cited by this paper
• Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.

  2004cited by this paper
• Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer

  2004cited by this paper
• LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane

  2004cited by this paper
• An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells

  2004cited by this paper
• TNF-α increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes

  2003cited by this paper
• Oncogenes in melanoma

  2003cited by this paper
• Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin

  2003cited by this paper
• TGF-β1 -promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-β1 -enhanced cell migration in SMMC-7721 cells

  2003cited by this paper
• Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.

  2003cited by this paper
• Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V.

  2003cited by this paper
• Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma.

  2003cited by this paper
• αvβ5 Integrin-Dependent Programmed Cell Death Triggered by a Peptide Mimic of Annexin V

  2003cited by this paper
• p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration

  2002cited by this paper
• Tumor necrosis factor or tumor promoting factor?

  2002cited by this paper
• Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas

  2002cited by this paper
• The Machinery of Blood Cell Movements

  2002cited by this paper
• Melanoma Cell Attachment, Invasion, and Integrin Expression is Upregulated by Tumor Necrosis Factor α and Suppressed by α Melanocyte Stimulating Hormone

  2002cited by this paper
• TGF-β1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G1 arrest

  2002cited by this paper
• TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.

  2002cited by this paper
• RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.

  2002cited by this paper
• Src in cancer: deregulation and consequences for cell behaviour.

  2002cited by this paper
• Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone.

  2002cited by this paper
• Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest.

  2001cited by this paper
• Gelsolin functions as a metasatsis suppressor in B16‐BL6 mouse melanoma cells and requirement of the carboxyl‐terminus for its effect

  2001cited by this paper
• CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration*

  2001cited by this paper
• Expression of the Cell Adhesion Molecules ICAM-1, VCAM-1 and NCAM in Uveal Melanoma: A Clinicopathological Study

  2000cited by this paper
• Monomeric midkine induces tumor cell proliferation in the absence of cell-surface proteoglycan binding.

  2000cited by this paper
• Cell crawling two decades after Abercrombie.

  1999cited by this paper
• Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

  1999cited by this paper
• Critical determinants of cancer metastasis: rationale for therapy

  1999cited by this paper
• Mechanisms of tumour metastasis.

  1998cited by this paper
• Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.

  1998cited by this paper
• Cancer metastasis: a search for therapeutic inhibition.

  1998cited by this paper
• The tumor-suppressor function of E-cadherin.

  1998cited by this paper
• The actin-binding proteins adseverin and gelsolin are both highly expressed but differentially localized in kidney and intestine.

  1998cited by this paper
• General mechanisms of metastasis

  1997cited by this paper
• Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy

  1997cited by this paper
• Tumor necrosis factor: function, release and clearance.

  1996cited by this paper
• Gelsolin: a candidate for suppressor of human bladder cancer.

  1995cited by this paper
• E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro.

  1994cited by this paper
• Differential expression of hsp90, gelsolin and gst-pi in human gastric-carcinoma cell-lines.

  1994cited by this paper
• The E. Donnall Thomas Lecture, 1993. The machinery of blood cell movements.

  1994cited by this paper
• Activity of pp60c-src in 60 different cell lines derived from human tumors.

  1994cited by this paper
• Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

  1994cited by this paper
• Differential Effects of Interleukin 1-α (IL-1α) or Tumor Necrosis Factor-α (TNF-α) on Motility of Human Melanoma Cell Lines on Fibronectin

  1994cited by this paper
• The E. Donnall Thomas Lecture, 1993. The machinery of blood cell movements

  1994cited by this paper
• Differential effects of interleukin 1-alpha (IL-1 alpha) or tumor necrosis factor-alpha (TNF-alpha) on motility of human melanoma cell lines on fibronectin.

  1994cited by this paper
• Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium.

  1993cited by this paper
• Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein.

  1990cited by this paper
• Muscle is the major source of plasma gelsolin.

  1988cited by this paper
• Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma

  1988influential reference
• Vimentin: an evaluation of its role as a tumour marker

  1987cited by this paper
• Reactivity of mouse monoclonal antibody M2590 against B16 melanoma cells with chemically synthesized GM3 ganglioside.

  1986cited by this paper
• Reactivity of mouse monoclonal antibody M2590 against B16 melanoma cells with chemically synthesized GM3 ganglioside.

  1986cited by this paper
• Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.

  1985cited by this paper
• Lipid composition of human malignant melanoma tumors at various levels of malignant growth.

  1979cited by this paper

• Melanoma and non-melanoma skin cancers represent the most common malignancies world-wide [ 2 , 3 ]

  2019cites this paper
• Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

  2019cites this paper
• An Update On Natural Compounds and Their Modern Formulations for the Management of Malignant Melanoma

  2017cites this paper
• Antitumor effect of the conjugate of synthetic carbohydrate moiety of the tumor-associated ganglioside GM3 with hemocyanin in combination with the cytostatic cyclophosphamide

  2014cites this paper